Stephanie Krebs

Stephanie Krebs is an accomplished executive with extensive experience in business development within the biotechnology and pharmaceutical sectors. Currently serving as Chief Business Officer at Sensei Bio, Stephanie has previously held similar roles at SNIPR Biome and HotSpot Therapeutics, Inc., after serving as VP and Head of Business Development at Valo and leading Severe Genetic Disease Business Development at bluebird bio. Prior experience includes strategic positions at Sobi and Biogen, where responsibilities encompassed neurology and immunology business development, along with commercial analytics. Stephanie's career commenced with roles in market research and business analysis, following a distinguished educational background that includes an MBA in Health Sciences from the University of Rochester, an MS in Biotechnology from The Johns Hopkins University, and a BS in Microbiology and Immunology from the University of Rochester.